S. Morry Blumenfeld is a Venture Partner in the Medical Technology Team at OurCrowd, Ltd. and the Chairman of the Medical Advisory Board of OurCrowd. He is the President and CEO of Quescon Consultants, Ltd, a medical device consulting company. Dr. Blumenfeld is also one of the Founding Partner of Meditech Advisors, LLC, and Meditech Advisors Management. The latter is one of the General Partners in the private equity fund, Ziegler Meditech Equity Partners, LP, specializing in investments in healthcare and medical device companies. He serves on the Board of or as a Consultant to a number of private medical device and technology companies and technology incubators, including InSightec, SightDx, AlphaTau Medical, Nanox Technology, Memic, 7D Surgical, and Illumigyn. Dr. Blumenfeld is currently on the Board of Directors of Aposense (an Israeli public company) and has served on the Board of MAKO Surgical acquired by Stryker, as well as the Board of Oridion before its acquisition by Covidien.
Dr. Blumenfeld worked for GE for over 34 years, including 27 years with GE Medical Systems and serving as Managing Director of GE Medical Systems in Israel. He is a prominent authority on the development and commercialization of healthcare technology including imaging devices and devices for minimally invasive procedures, and has advised or consulted with many medical research centers, universities, health technology companies and research hospitals across the USA, Europe and Asia. Morry holds five patents, and in 1977, GE’s Centennial Year, received the GE Centennial Award for his work in CT. Upon his retirement from GE Medical Systems he was honored by GE and cited for “contributions that have forever changed GE Medical Systems and the field of medical imaging.”